WY Chang

479 total citations
10 papers, 409 citations indexed

About

WY Chang is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, WY Chang has authored 10 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 8 papers in Epidemiology and 2 papers in Oncology. Recurrent topics in WY Chang's work include Liver Disease Diagnosis and Treatment (7 papers), Hepatitis B Virus Studies (6 papers) and Hepatitis C virus research (5 papers). WY Chang is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Hepatitis B Virus Studies (6 papers) and Hepatitis C virus research (5 papers). WY Chang collaborates with scholars based in Taiwan. WY Chang's co-authors include ZY Lin, JE Jeng, MY Hsieh, Su‐Ru Chen, Wan‐Long Chuang, C J Jeng, CY Dai, Ming‐Lung Yu, Jee‐Fu Huang and San‐Lin You and has published in prestigious journals such as British Journal of Cancer, Journal of Gastroenterology and Hepatology and Journal of Viral Hepatitis.

In The Last Decade

WY Chang

10 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
WY Chang Taiwan	10	278	267	71	68	50	10	409
Chien‐An Sun Taiwan	10	101 0.4×	234 0.9×	86 1.2×	211 3.1×	38 0.8×	13	470
Clémence Hollande France	8	69 0.2×	93 0.3×	99 1.4×	64 0.9×	37 0.7×	20	355
Mohammed Shatat Egypt	10	260 0.9×	294 1.1×	27 0.4×	28 0.4×	19 0.4×	16	364
P.L. Almasio Italy	9	246 0.9×	228 0.9×	27 0.4×	13 0.2×	12 0.2×	27	344
Christopherson Wm	10	33 0.1×	113 0.4×	65 0.9×	33 0.5×	4 0.1×	24	312
Lodovico Terzi di Bergamo Switzerland	7	78 0.3×	78 0.3×	46 0.6×	11 0.2×	21 0.4×	16	185
Charlotte Maulat France	11	133 0.5×	75 0.3×	163 2.3×	57 0.8×	2 0.0×	33	385
Haining Fan China	7	38 0.1×	47 0.2×	125 1.8×	71 1.0×	9 0.2×	29	291
Guy Rosner Israel	8	54 0.2×	66 0.2×	45 0.6×	40 0.6×	3 0.1×	19	212
Ellen B. Gurary United States	8	22 0.1×	37 0.1×	49 0.7×	82 1.2×	20 0.4×	14	239

Countries citing papers authored by WY Chang

Since Specialization

Citations

This map shows the geographic impact of WY Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by WY Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites WY Chang more than expected).

Fields of papers citing papers by WY Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by WY Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by WY Chang. The network helps show where WY Chang may publish in the future.

Co-authorship network of co-authors of WY Chang

This figure shows the co-authorship network connecting the top 25 collaborators of WY Chang. A scholar is included among the top collaborators of WY Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with WY Chang. WY Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Chen, Su‐Ru, et al.. (2013). Comparing self‐efficacy and self‐care behaviours between outpatients with comorbid schizophrenia and type 2 diabetes and outpatients with only type 2 diabetes. Journal of Psychiatric and Mental Health Nursing. 21(5). 414–422. 35 indexed citations

Huang, Jee‐Fu, Wan‐Long Chuang, CY Dai, et al.. (2006). The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon‐alpha and ribavirin combination therapy. Journal of Viral Hepatitis. 13(6). 396–401. 32 indexed citations

Dai, CY, Wan‐Long Chuang, ZY Lin, et al.. (2006). Associations of tumour necrosis factor alpha promoter polymorphisms at position ?308 and ?238 with clinical characteristics of chronic hepatitis C. Journal of Viral Hepatitis. 13(11). 770–774. 25 indexed citations

Jeng, JE, et al.. (1997). Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma. British Journal of Cancer. 75(10). 1460–1466. 36 indexed citations

Jeng, JE, et al.. (1997). Elevated urinary transforming growth factor-β1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma. British Journal of Cancer. 76(2). 244–250. 45 indexed citations

Jeng, JE, et al.. (1997). Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study. British Journal of Cancer. 76(7). 968–974. 115 indexed citations

Jeng, JE, et al.. (1996). Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma. British Journal of Cancer. 73(12). 1498–1502. 42 indexed citations

Jeng, JE, et al.. (1995). Clinical evaluation of serum α-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma. British Journal of Cancer. 72(2). 442–446. 22 indexed citations

Chang, WY, et al.. (1994). Frequency of raised α-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C. British Journal of Cancer. 69(6). 1157–1159. 44 indexed citations

10.

Chang, WY, et al.. (1992). Relationship between fatty liver, alanine aminotransferase, HBsAg and hepatitis C virus. Journal of Gastroenterology and Hepatology. 7(5). 455–458. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact